Dumanski, S.
64  Ergebnisse:
Personensuche X
?
 
?
2

POS-294 COX-2 INHIBITION AND KIDNEY HEMODYNAMICS: THE EFFEC..:

TURINO MIRANDA, K. ; Rytz, C. ; Dumanski, S...
Kidney International Reports.  6 (2021)  4 - p. S125-S126 , 2021
 
?
3

Parity and cardiovascular disease risk in women with chroni..:

Dumanski, S. ; Anderson, T. ; Kalenga, C....
Canadian Journal of Cardiology.  37 (2021)  2 - p. e13 , 2021
 
?
5

Serum Anti-Müllerian Hormone Levels and Measures of Arteria..:

Dumanski, S. ; Kalenga, C. ; Ramesh, S....
Canadian Journal of Cardiology.  34 (2018)  4 - p. e16 , 2018
 
?
 
?
7

Public coverage of Period Products and Contraception in Can..:

Niazi, E. ; Riehl-Tonn, V. ; Brennand, E....
Canadian Journal of Cardiology.  39 (2023)  5 - p. S13 , 2023
 
?
 
?
9

Correction: Sex and gender considerations in health researc..:

Kalenga, C. Z. ; Parsons Leigh, J. ; Griffith, J....
Humanities and Social Sciences Communications.  9 (2022)  1 - p. , 2022
 
?
 
?
 
?
12

Sex and gender considerations in health research: a trainee..:

Kalenga, C. Z. ; Parsons Leigh, J. ; Griffith, J....
Humanities and Social Sciences Communications.  7 (2020)  1 - p. , 2020
 
?
 
?
14

POS-291 ASSOCIATION BETWEEN CHRONIC KIDNEY DISEASE, MENSTRU..:

C. RYTZ ; G. Samadi Kochaksaraei ; L. Skeith..
http://www.sciencedirect.com/science/article/pii/S2468024921004526.  , 2021
 
?
15

POS-294 COX-2 INHIBITION AND KIDNEY HEMODYNAMICS: THE EFFEC..:

K. TURINO MIRANDA ; C. Rytz ; S. Dumanski..
http://www.sciencedirect.com/science/article/pii/S2468024921004551.  , 2021
 
1-15